Aradigm ( OTC:ARDM ) has filed for Chapter 11 bankruptcy in California. More news on: Aradigm Corp., Healthcare stocks news, Read more ...
Aradigm Corporation (OTCQB: ARDM) (“Aradigm” or the “Company”) has filed for protection under Chapter 11 of the U.S. Bankruptcy Code in the Alameda County Court District to facilitate the sale of its assets. On February 11, 2019, Aradigm determined that withou...
Aradigm ( OTC:ARDM ) has submitted its responses to the EMA's Day 120 questions related to its marketing application seeking approval for Apulmiq (ciprofloxacin for inhalation) for the treatment of non-cystic fibrosis bronchiectasis. The regulatory clock will now restart. It expects to rec...
Aradigm Corporation (OTCQB: ARDM) (“Aradigm” or the “Company”) submitted responses to the European Medicines Agency (EMA) Day 120 questions on 23 January 2019. The due date for response to the questions was 25 January. The submission of the responses to the questi...
The 20 stocks in the Premium Portfolio from my membership service that draws from a wide range of different models in the financial literature has surged to 15% gains through January. These gains again appear to be primarily based on the strength of momentum and forensic negative stock selecti...
News, Short Squeeze, Breakout and More Instantly...
Aradigm Corporation (OTCQB: ARDM) (“Aradigm” or the “Company”) has filed for protection under Chapter 11 of the U.S. Bankruptcy Code in the Alameda County Court District to facilitate the sale of its assets. On February 11, 2019, Aradigm determined that withou...
Aradigm Corporation (OTCQB: ARDM) (“Aradigm” or the “Company”) submitted responses to the European Medicines Agency (EMA) Day 120 questions on 23 January 2019. The due date for response to the questions was 25 January. The submission of the responses to the questi...